Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.625 USD | +1.00% | -2.41% | +38.27% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.27% | 322M | |
-1.83% | 103B | |
+0.55% | 95.71B | |
+1.69% | 22.02B | |
-16.72% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.83% | 15.52B | |
+3.93% | 13.86B | |
+35.00% | 12.04B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences : Reports Additional Pulmonary Function Data From Phase 1/2 Clinical Trial of Duchenne Therapy Candidate